NCT00595829 - A Phase 1 Study of XL019 in Adults With Polycythemia Vera | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Polycythemia Vera

Interventions

DRUG

XL019

XL019 capsules administered orally

Trial Locations (5)

Weill Cornell Medical College, New York

H. Lee Moffitt Cancer Center & Research Institute, Tampa

University of Michigan Health System, Ann Arbor

UCLA School of Medicine, Center for Health Sciences, Los Angeles

UCSF - Division of Hematology/Oncology, San Francisco